Avalo Therapeutics, Inc. (AVTX)

USD 9.28

(-1.07%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 20.99 Million 33.36 Million 80.21 Million 43.75 Million 36.1 Million 70.25 Million
Total Current Assets 8.39 Million 16.41 Million 61.84 Million 26 Million 17.72 Million 21.93 Million
Cash And Short Term Investments 7.41 Million 13.17 Million 54.58 Million 18.91 Million 11.23 Million 10.64 Million
Cash and Cash Equivalents 7.41 Million 13.17 Million 54.58 Million 18.91 Million 3.6 Million 10.64 Million
Short Term Investments - - - - 7.62 Million -
Net Receivables 136 Thousand 1.91 Million 4.79 Million 4.38 Million 5.24 Million 8.62 Million
Inventory - 20 Thousand 38 Thousand 3000.00 21 Thousand 1.11 Million
Other Current Assets 843 Thousand 1.29 Million 2.37 Million 2.66 Million 707 Thousand 1.52 Million
Total Non-Current Assets 12.59 Million 16.95 Million 18.36 Million 17.75 Million 18.38 Million 48.31 Million
Net PPE 1.96 Million 2.41 Million 2.69 Million 1.6 Million 1.44 Million 586.51 Thousand
Good Will And Intangible Assets 10.5 Million 14.4 Million 14.44 Million 15.99 Million 16.83 Million 47.65 Million
Good Will 10.5 Million 14.4 Million 14.4 Million 14.4 Million 14.4 Million 16.41 Million
Intangible Assets - - 38 Thousand 1.58 Million 2.42 Million 31.23 Million
Long-Term Investments 131 Thousand 131 Thousand 227 Thousand 148.64 Thousand 101.94 Thousand 81.72 Thousand
Tax Assets -131 Thousand -131 Thousand -227 Thousand -148.64 Thousand -101.94 Thousand 91.23 Thousand
Other Non Current Assets 131 Thousand 131 Thousand 1.22 Million 149 Thousand 102 Thousand -91.23 Thousand
Other Assets 1.00 - - - - -
Total Liabilities 13.68 Million 44.28 Million 57.13 Million 19.19 Million 15.11 Million 49.34 Million
Total Current Liabilities 4.61 Million 22.11 Million 19.88 Million 15.22 Million 12.16 Million 26.21 Million
Account Payables 446 Thousand 2.88 Million 3.36 Million 2.57 Million 2.07 Million 1.44 Million
Tax Payables - - - - 552 Thousand 2.03 Million
Short Term Debt 537 Thousand 5.93 Million 485 Thousand 426.34 Thousand 155.81 Thousand 1.05 Million
Deferred Revenue - 88 Thousand 16.02 Million 10.88 Million -155.81 Thousand 2.03 Million
Other Current Liabilities 3.63 Million 13.21 Million 9000.00 1.34 Million 10.08 Million 21.68 Million
Total Non Current Liabilities 9.07 Million 22.16 Million 37.24 Million 3.96 Million 2.95 Million 23.12 Million
Long-Term Debt 2 Million 13.48 Million 32.83 Million 2 Million 1.11 Million 14.32 Million
Deferred Revenue Non Current 1.36 Million - - -2 Million -1.11 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 5.55 Million 8.54 Million 4.29 Million 3.87 Million 2.86 Million 8.72 Million
Other Liabilities - - - - - -
Total Equity 7.3 Million -10.91 Million 23.08 Million 24.56 Million 20.99 Million 20.9 Million
Stock Holders Equity 7.3 Million -10.91 Million 23.08 Million 24.56 Million 20.99 Million 20.9 Million
Common Stock 1000.00 9000.00 113 Thousand 75 Thousand 44 Thousand 40.8 Thousand
Retained Earnings -335.13 Million -303.82 Million -262.16 Million -177.79 Million -114.29 Million -98.21 Million
Accumulated other comprehensive income - - - - - -
Common Stock Equity 7.3 Million -10.91 Million 23.08 Million 24.56 Million 20.99 Million 20.9 Million
Capital Lease Obligation 1.36 Million 532 Thousand 485 Thousand 426.34 Thousand 1.11 Million -
Total Investments 131 Thousand 131 Thousand 227 Thousand 148.64 Thousand 7.62 Million 81.72 Thousand
Total Debt 3.9 Million 19.41 Million 32.83 Million 426.34 Thousand 1.26 Million 15.37 Million
Net Debt -3.51 Million 6.24 Million -21.75 Million -18.49 Million -2.34 Million 4.73 Million

Balance Sheet Charts